A Phase III Double-Blind, Placebo Controlled Study Of The Safety And Efficacy Of 10mg Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer

Project Details

Short titleA Phase III Double-Blind, Placebo Controlled Study Of The Safety And Efficacy Of 10mg Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer
StatusFinished
Effective start/end date1/01/02 → 31/12/05

Funding

  • PPD GLOBAL LTD